Murfreesboro Medical Clinic and SurgiCenter partners with 2bPrecise for precision medicine
May 07 2019 - 8:01AM
Business Wire
Tennessee provider seeks to make genomic
information easily available at the point of care
Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) announced
today that Murfreesboro Medical Clinic and SurgiCenter (MMC) has
selected 2bPrecise™ to support its precision medicine strategy,
beginning with pharmacogenomics (PGx) at the point of care.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190507005275/en/
The only multispecialty, physician-owned clinic in Rutherford
County, TN, MMC became an advocate of genomics and PGx several
years ago, with providers ordering molecular tests for select
patients to support diagnostic and treatment decisions. They found
it difficult to apply genomic insights to medical decisions during
patient encounters, however, because test results were not
integrated with clinical information or easily available within the
EHR workflow.
“We’re deeply committed to providing exceptional care to members
of our community,” says Nicholas Cote, D.O., CMIO and President of
the Board for MMC. “We recognize that using science to drive
medical treatment is infinitely more effective than trial and
error. The 2bPrecise platform will help equip our clinicians to
identify the best medications for individual patients, achieving
better results faster and with fewer side effects. Not only is this
good medicine, but it greatly enhances the patient experience as
well.”
2bPrecise, a wholly owned Allscripts subsidiary, developed its
platform to serve as the final bridge between the science of
genomics and clinical application. It consumes data from any lab
source or knowledge base and delivers it in an actionable format
and vocabulary to the clinical workflow, regardless of the
provider’s EHR.
Dr. Cote notes that use of PGx test results in family practice
is especially beneficial, as it serves as the “epicenter” of care,
with primary care providers supporting the overall management of
the patient. Over time, leadership at MMC anticipates expanding to
areas of precision medicine beyond PGx. The 2bPrecise solution can
serve as the foundation for long-term needs, enabling MMC to help
clinicians identify patients at risk for heritable diseases across
specialties, arrive at precise diagnoses earlier and ultimately
select the best treatment based on the patient’s genetic
profile.
Implementation of the platform is underway, with go-live
anticipated later this year. 2bPrecise will be integrated with
MMC’s current clinical systems, including Allscripts TouchWorks®
EHR. Relevant PGx information will be brought to the provider’s
attention via the 2bPrecise Genomic EHR Mentor (GEM™), an applet
that floats on top of the EHR workflow.
“We’re delighted to partner with Dr. Cote and his team on MMC’s
precision medicine strategy,” says Assaf Halevy, founder and CEO of
2bPrecise. “It’s clear that MMC leadership has a long-term vision
to leverage innovation for the good of the patient, a mission that
aligns closely with 2bPrecise’s corporate values.”
About 2bPrecise
The cloud-based 2bPrecise platform consumes genomic/genetic data
(from any molecular lab) and clinical information (from any EHR),
combining them into a comprehensive patient record. The solution
applies insights from multiple curated, evidence-based
knowledgebases and then injects the data back into the provider’s
native workflow. The 2bPrecise platform creates a discrete
information layer that follows the patient as he or she moves into
various clinical settings, so the entire care team can access
valuable insights – preventing information from being isolated in a
single care encounter or specialty area, while enabling providers
to arrive at accurate diagnoses sooner and deliver therapeutic
value faster. Learn more at www.2bPreciseHealth.com.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial and
operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers and consumers to make better
decisions, delivering better care for healthier populations. To
learn more, visit www.allscripts.com, Twitter,
YouTube and It Takes A Community: The Allscripts
Blog.
© 2019 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are
trademarks of Allscripts Healthcare, LLC and/or its affiliates. All
other products are trademarks of their respective holders, all
rights reserved. Reference to these products is not intended to
imply affiliation with or sponsorship of Allscripts Healthcare, LLC
and/or its affiliates.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190507005275/en/
Investors:Stephen
Shulstein312-386-6735Stephen.Shulstein@allscripts.comMedia:Concetta
RasiarmosAllscripts312-447-2466concetta.rasiarmos@allscripts.comDanielle
JohnsAria Marketing for 2bPrecise617-332-9999 ext.
241djohns@ariamarketing.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024